{"count": 20, "results": [{"_id": "36147344", "pmid": 36147344, "pmcid": "PMC9486097", "title": "Literature review of the clinical characteristics of metformin-induced hepatotoxicity", "journal": "Front Pharmacol", "authors": ["Wang C", "Deng H", "Xu Y", "Liu Y"], "date": "2022-09-06T00:00:00Z", "doi": "10.3389/fphar.2022.969505", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "969505", "score": 50266.715, "text_hl": "Literature review of the clinical characteristics of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-induced hepatotoxicity", "citations": {"NLM": "Wang C, Deng H, Xu Y, Liu Y. Literature review of the clinical characteristics of metformin-induced hepatotoxicity Front Pharmacol. 2022;13():969505. PMID: 36147344", "BibTeX": "@article{36147344, title={Literature review of the clinical characteristics of metformin-induced hepatotoxicity}, author={Wang C and Deng H and Xu Y and Liu Y}, journal={Front Pharmacol}, volume={13}, pages={969505}}"}}, {"_id": "37131014", "pmid": 37131014, "pmcid": "PMC10220128", "title": "The Effect of Metformin on Chemotherapy-Induced Toxicities in Non-diabetic Breast Cancer Patients: A Randomised Controlled Study", "journal": "Drug Saf", "authors": ["Serageldin MA", "Kassem AB", "El-Kerm Y", "Helmy MW", "El-Mas MM", "El-Bassiouny NA"], "date": "2023-06-01T00:00:00Z", "doi": "10.1007/s40264-023-01305-4", "meta_date_publication": "2023 Jun", "meta_volume": "46", "meta_issue": "6", "meta_pages": "587-599", "score": 50266.14, "text_hl": "...Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@Fatigue@@@", "citations": {"NLM": "Serageldin MA, Kassem AB, El-Kerm Y, Helmy MW, El-Mas MM, El-Bassiouny NA. The Effect of Metformin on Chemotherapy-Induced Toxicities in Non-diabetic Breast Cancer Patients: A Randomised Controlled Study Drug Saf. 2023 Jun;46(6):587-599. PMID: 37131014", "BibTeX": "@article{37131014, title={The Effect of Metformin on Chemotherapy-Induced Toxicities in Non-diabetic Breast Cancer Patients: A Randomised Controlled Study}, author={Serageldin MA and Kassem AB and El-Kerm Y and Helmy MW and El-Mas MM and El-Bassiouny NA}, journal={Drug Saf}, volume={46}, number={6}, pages={587-599}}"}}, {"_id": "36384864", "pmid": 36384864, "pmcid": "PMC9679981", "title": "Unusual Case of Metformin-Associated Lactic Acidosis in Patient with Type 2 Diabetes Mellitus", "journal": "Am J Case Rep", "authors": ["Hai PD", "Thu NT", "Phuong LL", "Manh NV", "Hoa LTV"], "date": "2022-11-17T00:00:00Z", "doi": "10.12659/AJCR.937865", "meta_date_publication": "2022 Nov 17", "meta_volume": "23", "meta_issue": "", "meta_pages": "e937865", "score": 50255.617, "text_hl": "... Final Diagnosis: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ associated @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@ ", "citations": {"NLM": "Hai PD, Thu NT, Phuong LL, Manh NV, Hoa LTV. Unusual Case of Metformin-Associated Lactic Acidosis in Patient with Type 2 Diabetes Mellitus Am J Case Rep. 2022 Nov 17;23():e937865. PMID: 36384864", "BibTeX": "@article{36384864, title={Unusual Case of Metformin-Associated Lactic Acidosis in Patient with Type 2 Diabetes Mellitus}, author={Hai PD and Thu NT and Phuong LL and Manh NV and Hoa LTV}, journal={Am J Case Rep}, volume={23}, pages={e937865}}"}}, {"_id": "34075013", "pmid": 34075013, "pmcid": "PMC8183305", "title": "Symptomatic Hypoglycemia During Treatment with a Therapeutic Dose of Metformin", "journal": "Am J Case Rep", "authors": ["Joseph CMC"], "date": "2021-06-02T00:00:00Z", "doi": "10.12659/AJCR.931311", "meta_date_publication": "2021 Jun 2", "meta_volume": "22", "meta_issue": "", "meta_pages": "e931311", "score": 50253.395, "text_hl": "Within 2 weeks of discontinuing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, there were no further \"attacks\", and the chronic @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@daytime fatigue@@@ and @DISEASE_Disorders_of_Excessive_Somnolence @DISEASE_MESH:D006970 @@@somnolence@@@ significantly improved.", "citations": {"NLM": "Joseph CMC. Symptomatic Hypoglycemia During Treatment with a Therapeutic Dose of Metformin Am J Case Rep. 2021 Jun 2;22():e931311. PMID: 34075013", "BibTeX": "@article{34075013, title={Symptomatic Hypoglycemia During Treatment with a Therapeutic Dose of Metformin}, author={Joseph CMC}, journal={Am J Case Rep}, volume={22}, pages={e931311}}"}}, {"_id": "34234490", "pmid": 34234490, "pmcid": "PMC8254563", "title": "Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study", "journal": "Diabetes Metab Syndr Obes", "authors": ["Mohan V", "Zargar A", "Chawla M", "Joshi A", "Ayyagari U", "Sethi B", "Gaurav K", "Patted URH", "Bhagat SV", "Mane AI"], "date": "2021-06-29T00:00:00Z", "doi": "10.2147/DMSO.S315227", "meta_date_publication": "2021", "meta_volume": "14", "meta_issue": "", "meta_pages": "2925-2933", "score": 50253.05, "text_hl": "The current study showed that adverse events such as giddiness, @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@fatigue@@@ and @DISEASE_Stomach_Diseases @DISEASE_MESH:D013272 @@@gastric discomfort@@@ were similar for the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ only arm and the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ plus @CHEMICAL_Vildagliptin @CHEMICAL_MESH:D000077597 @@@vildagliptin@@@ arm. ", "citations": {"NLM": "Mohan V, Zargar A, Chawla M, Joshi A, Ayyagari U, Sethi B, Gaurav K, Patted URH, Bhagat SV, Mane AI. Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study Diabetes Metab Syndr Obes. 2021;14():2925-2933. PMID: 34234490", "BibTeX": "@article{34234490, title={Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study}, author={Mohan V and Zargar A and Chawla M and Joshi A and Ayyagari U and Sethi B and Gaurav K and Patted URH and Bhagat SV and Mane AI}, journal={Diabetes Metab Syndr Obes}, volume={14}, pages={2925-2933}}"}}, {"_id": "36613942", "pmid": 36613942, "pmcid": "PMC9820761", "title": "Metformin Attenuates Slow-to-Fast Fiber Shift and Proteolysis Markers Increase in Rat Soleus after 7 Days of Rat Hindlimb Unloading", "journal": "Int J Mol Sci", "authors": ["Sharlo KA", "Lvova ID", "Belova SP", "Zaripova KA", "Shenkman BS", "Nemirovskaya TL"], "date": "2022-12-28T00:00:00Z", "doi": "10.3390/ijms24010503", "meta_date_publication": "2022 Dec 28", "meta_volume": "24", "meta_issue": "1", "meta_pages": "", "score": 50239.734, "text_hl": "Thus, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment during @DISEASE_Muscular_Disorders_Atrophic @DISEASE_MESH:D020966 @@@muscle disuse@@@ could be useful to prevent the decrease in the percentage of slow-type @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@fatigue@@@-resistant muscle fibers.", "citations": {"NLM": "Sharlo KA, Lvova ID, Belova SP, Zaripova KA, Shenkman BS, Nemirovskaya TL. Metformin Attenuates Slow-to-Fast Fiber Shift and Proteolysis Markers Increase in Rat Soleus after 7 Days of Rat Hindlimb Unloading Int J Mol Sci. 2022 Dec 28;24(1):. PMID: 36613942", "BibTeX": "@article{36613942, title={Metformin Attenuates Slow-to-Fast Fiber Shift and Proteolysis Markers Increase in Rat Soleus after 7 Days of Rat Hindlimb Unloading}, author={Sharlo KA and Lvova ID and Belova SP and Zaripova KA and Shenkman BS and Nemirovskaya TL}, journal={Int J Mol Sci}, volume={24}, number={1}}"}}, {"_id": "35282610", "pmid": 35282610, "pmcid": "PMC8906987", "title": "Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor", "journal": "Case Rep Endocrinol", "authors": ["Alhemeiri M", "Alseddeeqi E"], "date": "2022-03-02T00:00:00Z", "doi": "10.1155/2022/4101975", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "4101975", "score": 50236.58, "text_hl": "We report a case of a 45-year-old gentleman with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ on @CHEMICAL_empagliflozin @CHEMICAL_MESH:C570240 @@@empagliflozin@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and @CHEMICAL_glimepiride @CHEMICAL_MESH:C057619 @@@glimepiride@@@ who presented with @DISEASE_Abdominal_Pain @DISEASE_MESH:D015746 @@@abdominal pain@@@, @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@fatigue@@@, and @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@. ", "citations": {"NLM": "Alhemeiri M, Alseddeeqi E. Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor Case Rep Endocrinol. 2022;2022():4101975. PMID: 35282610", "BibTeX": "@article{35282610, title={Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor}, author={Alhemeiri M and Alseddeeqi E}, journal={Case Rep Endocrinol}, volume={2022}, pages={4101975}}"}}, {"_id": "36464072", "pmid": 36464072, "title": "[Cross-Sectional Study on Adverse Effects of Metformin Hydrochloride on 130 Patients Type 2 Diabetic Admitted to Medical Center and Diabetes Home of Sidi Bel-Abbes].", "journal": "Ann Pharm Fr", "authors": ["Sakouhi M", "Matmour D", "Belakhdar K", "Kraroubi A"], "date": "2022-12-02T00:00:00Z", "doi": "10.1016/j.pharma.2022.11.013", "meta_date_publication": "2022 Dec 2", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50233.68, "text_hl": "Five (3.85%) @SPECIES_9606 @@@patients@@@ had a total and lasting intolerance to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MetforminHydrochloride@@@ leading to its discontinuation following persistent @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhoea@@@. ", "citations": {"NLM": "Sakouhi M, Matmour D, Belakhdar K, Kraroubi A. [Cross-Sectional Study on Adverse Effects of Metformin Hydrochloride on 130 Patients Type 2 Diabetic Admitted to Medical Center and Diabetes Home of Sidi Bel-Abbes]. Ann Pharm Fr. 2022 Dec 2;():. PMID: 36464072", "BibTeX": "@article{36464072, title={[Cross-Sectional Study on Adverse Effects of Metformin Hydrochloride on 130 Patients Type 2 Diabetic Admitted to Medical Center and Diabetes Home of Sidi Bel-Abbes].}, author={Sakouhi M and Matmour D and Belakhdar K and Kraroubi A}, journal={Ann Pharm Fr}}"}}, {"_id": "35391603", "pmid": 35391603, "title": "A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors.", "journal": "Neurol Sci", "authors": ["Stella M", "Biassoni E", "Fiorillo C", "Grandis M", "Mattioli F", "Del Sette M"], "date": "2022-07-01T00:00:00Z", "doi": "10.1007/s10072-022-06046-3", "meta_date_publication": "2022 Jul", "meta_volume": "43", "meta_issue": "7", "meta_pages": "4567-4570", "score": 50233.137, "text_hl": "We report the case of a 76-year-old @SPECIES_9606 @@@woman@@@ who developed @DISEASE_Muscle_Weakness @DISEASE_MESH:D018908 @@@muscle weakness@@@, @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@fatigue@@@, and increased CK, following treatment with @CHEMICAL_dapagliflozin @CHEMICAL_MESH:C529054 @@@dapagliflozin@@@, a sodium/glucose co-transporter 2 (SGLT2) inhibitor, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Stella M, Biassoni E, Fiorillo C, Grandis M, Mattioli F, Del Sette M. A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors. Neurol Sci. 2022 Jul;43(7):4567-4570. PMID: 35391603", "BibTeX": "@article{35391603, title={A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors.}, author={Stella M and Biassoni E and Fiorillo C and Grandis M and Mattioli F and Del Sette M}, journal={Neurol Sci}, volume={43}, number={7}, pages={4567-4570}}"}}, {"_id": "32200516", "pmid": 32200516, "title": "Glucose Uptake and Insulin Response in Tissue-engineered Human Skeletal Muscle.", "journal": "Tissue Eng Regen Med", "authors": ["Kondash ME", "Ananthakumar A", "Khodabukus A", "Bursac N", "Truskey GA"], "date": "2020-12-01T00:00:00Z", "doi": "10.1007/s13770-020-00242-y", "meta_date_publication": "2020 Dec", "meta_volume": "17", "meta_issue": "6", "meta_pages": "801-813", "score": 50229.812, "text_hl": "Treatment of myobundles with 400 microM @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ increased basal @CHEMICAL_Deoxyglucose @CHEMICAL_MESH:D003847 @@@2-DG@@@ uptake 1.7-fold and caused a significant drop in twitch and tetanus contractile force along with decreased @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@fatigue@@@ resistance. ", "citations": {"NLM": "Kondash ME, Ananthakumar A, Khodabukus A, Bursac N, Truskey GA. Glucose Uptake and Insulin Response in Tissue-engineered Human Skeletal Muscle. Tissue Eng Regen Med. 2020 Dec;17(6):801-813. PMID: 32200516", "BibTeX": "@article{32200516, title={Glucose Uptake and Insulin Response in Tissue-engineered Human Skeletal Muscle.}, author={Kondash ME and Ananthakumar A and Khodabukus A and Bursac N and Truskey GA}, journal={Tissue Eng Regen Med}, volume={17}, number={6}, pages={801-813}}"}}]}